Aspetic pharmaceutical tech expert Telstar acquired by Syntegon

By Sophie Bullimore | Published: 10-Jun-2024
Finance Pharmaceutical

Japan-based Azbil Corporation has announced plans to sell its aseptic process solutions expert Telstar to Germany-based Syntegon

You need to be a subscriber to read this article.
Click here to find out more.

The global brand of aseptic process solutions, Spain-based Telstar, has announced plans to join Germany-based Syntegon.

The acquisition by Syntegon has been announced by them, as well as by the current owners of Telstar, Japan-based Azbil Corporation.

Cleanroom Technology reached out to Telstar about any changes cleanroom operators using or installing Telstar tech can expect.

CEO, Jordi Puig, responded and said: "No major changes are expected regarding Telstar technology that may affect cleanrooms or facilities."

What synergies will the company have?

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Telstar Group
  • Azbil
  • Syntegon Technology
See more

You may also like

Finance

Azbil completes transfer of aseptic process solutions to expert Telstar to Syntegon

Read more
Japan-based Azbil Corporation has officially transferred all of the equity interests in its European subsidiary Azbil Telstar to a wholly owned subsidiary of Syntegon Technology

Trending Articles

  1. The three musketeers of pharmaceutical quality control GMP, GAMP5, and 21CFR11 explained
  2. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  3. Thermo Fisher Scientific opens sterile drug facility in Asia The global company has built a new manufacturing facility and expanded capabilities in Singapore to enable the country’s science and technology sector to accelerate research, development and manufacturing of critical medicines and vaccines
  4. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    The importance of growth promotion testing Given the critical nature of microbiological quality tests which are employed to ensure that pharmaceutical products are safe for human use, it is in turn essential to undertake quality control (QC) tests to ensure that the culture media being used for these is fit for purpose and performs properly. Cherwell Laboratories' Steven Brimble explains

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Finance

Azbil completes transfer of aseptic process solutions to expert Telstar to Syntegon

Japan-based Azbil Corporation has officially transferred all of the equity interests in its European subsidiary Azbil Telstar to a wholly owned subsidiary of Syntegon Technology
Design & Build

Life science equipment provider Telstar launches extra-large BSC for cytometers and robots

Telstar has launched BioMax, a new large-scale Class II biological safety cabinet designed to support objects over 500mm high or deep inside the cabinet, such as cytometers and robots
Analysis

Syntegon launches new "Settle Plate Changer" for automated viable monitoring

Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
Regulatory

EU GMP Annex 1 compliance: should you get new equipment or upgrade?

Buy a new machine or upgrade the existing equipment? In light of Annex 1, pharmaceutical manufacturers and contract manufacturing organisations are facing this question more than ever. Steffen Mueller discusses the solution Syntegon worked on with AJ Vaccines
Regulatory

Impact of the new Annex 1 on sterile filling in pharma

EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes Rauschnabel from Syntegon discusses how equipment suppliers can help with implementation
Containment

Life science equipment provider Telstar upgrades Chinese production to 5,200 sqm facility

Telstar has expanded production capacity with a larger, more modern facility, to better serve the Asia-Pacific region
Cleaning

Should you automate your processes in pharmaceutical sterilisation?

A look at the factors that come into play when deciding whether to integrate automation into pharmaceutical manufacturing processes. Jordi Martinez from Telstar explains
Subscribe now